Grand Jean Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,998
| Closed | -$1.6M | – | 2 |
|
|
2024
Q4 | $1.6M | Hold |
8,998
| – | – | 0.37% | 32 |
|
|
2024
Q3 | $1.78M | Hold |
8,998
| – | – | 0.4% | 33 |
|
|
2024
Q2 | $1.54M | Hold |
8,998
| – | – | 0.38% | 29 |
|
|
2024
Q1 | $1.64M | Hold |
8,998
| – | – | 0.43% | 28 |
|
|
2023
Q4 | $1.39M | Hold |
8,998
| – | – | 0.42% | 29 |
|
|
2023
Q3 | $1.32M | Hold |
8,998
| – | – | 0.41% | 27 |
|
|
2023
Q2 | $1.21M | Hold |
8,998
| – | – | 0.41% | 27 |
|
|
2023
Q1 | $1.43M | Hold |
8,998
| – | – | 0.55% | 24 |
|
|
2022
Q4 | $1.45M | Hold |
8,998
| – | – | 0.66% | 22 |
|
|
2022
Q3 | $1.21M | Hold |
8,998
| – | – | 0.54% | 23 |
|
|
2022
Q2 | $1.38M | Hold |
8,998
| – | – | 0.55% | 24 |
|
|
2022
Q1 | $1.46M | Buy |
8,998
+99
| +1% | +$14.4K | 0.4% | 32 |
|
|
2021
Q4 | $1.21M | Buy |
+8,899
| New | +$1.05M | 0.3% | 35 |
|
|
2019
Q2 | – | Sell |
-6,055
| Closed | -$488K | – | 36 |
|
|
2019
Q1 | $488K | Sell |
6,055
-4,000
| -40% | -$327K | 0.2% | 31 |
|
|
2018
Q4 | $927K | Hold |
10,055
| – | – | 0.45% | 26 |
|
|
2018
Q3 | $951K | Hold |
10,055
| – | – | 0.33% | 30 |
|
|
2018
Q2 | $932K | Hold |
10,055
| – | – | 0.33% | 30 |
|
|
2018
Q1 | $952K | Hold |
10,055
| – | – | 0.36% | 30 |
|
|
2017
Q4 | $972K | Sell |
10,055
-1,110
| -10% | -$105K | 0.33% | 31 |
|
|
2017
Q3 | $992K | Hold |
11,165
| – | – | 0.36% | 29 |
|
|
2017
Q2 | $810K | Hold |
11,165
| – | – | 0.31% | 28 |
|
|
2017
Q1 | $728K | Sell |
11,165
-334
| -3% | -$21K | 0.27% | 26 |
|
|
2016
Q4 | $720K | Hold |
11,499
| – | – | 0.27% | 24 |
|
|
2016
Q3 | $725K | Hold |
11,499
| – | – | 0.31% | 22 |
|
|
2016
Q2 | $712K | Hold |
11,499
| – | – | 0.31% | 24 |
|
|
2016
Q1 | $657K | Hold |
11,499
| – | – | 0.28% | 21 |
|
|
2015
Q4 | $681K | Hold |
11,499
| – | – | 0.3% | 22 |
|
|
2015
Q3 | $626K | Hold |
11,499
| – | – | 0.28% | 27 |
|
|
2015
Q2 | $773K | Hold |
11,499
| – | – | 0.3% | 26 |
|
|
2015
Q1 | $673K | Hold |
11,499
| – | – | 0.25% | 24 |
|
|
2014
Q4 | $752K | Hold |
11,499
| – | – | 0.29% | 25 |
|
|
2014
Q3 | $664K | Hold |
11,499
| – | – | 0.26% | 26 |
|
|
2014
Q2 | $649K | Hold |
11,499
| – | – | 0.21% | 27 |
|
|
2014
Q1 | $591K | Hold |
11,499
| – | – | 0.21% | 26 |
|
|
2013
Q4 | $607K | Hold |
11,499
| – | – | 0.21% | 26 |
|
|
2013
Q3 | $514K | Sell |
11,499
-1,300
| -10% | -$57.6K | 0.17% | 25 |
|
|
2013
Q2 | $529K | Buy |
+12,799
| New | +$560K | 0.21% | 27 |
|
Other funds holding ABBV
Grand Jean Capital Management's ABBV Position: Q1 2025 in Review
Grand Jean Capital Management sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 8,998 shares — an estimated $1.6M sold.
Grand Jean Capital Management first reported a position in ABBV in Q2 2013 and held it in 37 quarters. The position peaked at $1.78M in Q3 2024. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.
- Grand Jean Capital Management reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
- Grand Jean Capital Management sold 8,998 AbbVie shares in Q1 2025, an estimated $1.6M.
- Grand Jean Capital Management first reported a position in AbbVie in Q2 2013 and held it in 37 quarters.
- Grand Jean Capital Management's AbbVie position peaked at $1.78M in Q3 2024.
- 3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.
Based on Grand Jean Capital Management's 13F filing for Q1 2025.